Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
92 hedge funds and large institutions have $19.5M invested in Zomedica Corp. in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 8 closing their positions.
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
2% more funds holding
Funds holding: 90 → 92 (+2)
5% less capital invested
Capital invested by funds: $20.4M → $19.5M (-$939K)
13% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$257K |
| 2 |
ProShare Advisors
Bethesda,
Maryland
|
+$166K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$66.2K |
| 4 |
Squarepoint
New York
|
+$64.8K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$41.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWMG
Pinnacle Wealth Management Group
Plymouth,
Michigan
|
-$206K |
| 2 |
Jane Street
New York
|
-$140K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$48.7K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$36.4K |
| 5 |
Bank of New York Mellon
New York
|
-$29.3K |
ZOM Hedge Fund Activity: Q2 2023 in Review
92 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q2 2023, worth a combined $19.5M — down 4.6% from $20.4M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ZOM positions and 8 closed out — a net gain of 2 holders — while 13 added to existing stakes and 15 trimmed.
The largest buyer was BlackRock, adding an estimated $257K. The largest seller was Pinnacle Wealth Management Group, exiting entirely with an estimated $206K sold.
- 92 institutional investors held Zomedica Corp. (ZOM) as of Q2 2023, up from 90 in Q1 2023.
- Funds reported $19.5M of Zomedica Corp. stock for Q2 2023, down 4.6% quarter-over-quarter.
- 10 funds opened new Zomedica Corp. positions in Q2 2023 and 8 closed out, a net change of +2 holders.
- The largest Zomedica Corp. buyer in Q2 2023 was BlackRock, an estimated $257K added.
- The largest Zomedica Corp. seller in Q2 2023 was Pinnacle Wealth Management Group, an estimated $206K sold.
Based on aggregated 13F filings for Q2 2023.